REPLACEMENT RELEASE: 8th European Congress on Hematologic Malignancies from Clinical Science to Clinical PracticeContinuing Medical Education Conference

Share Article

For more information and to register for the 8th European Congress on Hematologic Malignancies: From Clinical Science to Clinical Practice on February 24-26, 2012 in Amsterdam, The Netherlands please contact us: E-mail us at registration(at)imedex(dot)com. Call us at +1 (678) 242 0906 or register online at http://www.europeanhematologicmalignancies.com. About Imedex, LLC Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.

News Image

Past News Releases

RSS

Imedex, LLC would like to present the 8th European Congress on Hematologic Malignancies: From Clinical Science to Clinical Practice conference which will be held from 24-26 February 2012 in Amsterdam, The Netherlands. This continuing medical education (CME) meeting has a target audience of hematologists, oncologists, and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians' assistants, etc.) involved and/or interested in the therapeutic management of patients with hematologic malignancies, including multiple myeloma, chronic lymphocytic leukemia, and Hodgkin's and non-Hodgkin lymphomas.

This online gastroenterology CME opportunity will provide a forum to review state-of-the-art medical techniques and present new data, as well as give attendees the opportunity to exchange ideas with world-renowned opinion leaders in the field. The Congress will specifically focus on hematologic malignancies, including myeloma, lymphoma, and leukemia, as well as discussions on screening, diagnosis and the latest management options.

Upon completion of this oncology CME opportunity, participants can expect to:

  •     Increase awareness and knowledge regarding:
  •     The evolving role of transplantation in managing hematologic malignancies
  •     The changing role of radiation therapy in treating hematologic malignancies
  •     Demonstrate a greater confidence in their ability to:
  •     Incorporate latest data into treatment plans for newly diagnosed hematologic malignancies
  •     Apply novel agents and strategies to treatment of relapsed and/or refractory disease
  •     Increase the frequency (compared with current level) which with they plan to:
  •     Use prognostic tools such as imaging, cytogenetics, and risk stratification to guide treatment decisions for patients with hematologic malignancies
  •     Recommend maintenance therapy for appropriate patients with hematologic malignancies
  •     Enroll patients with difficult-to-treat hematologic malignancies in clinical trials of novel agents

This oncology CME meeting will be held in Amsterdam on 24-26 February 2012.

For more information and to register for the 8th European Congress on Hematologic Malignancies: From Clinical Science to Clinical Practice on 24-26 February 2012 in Amsterdam, The Netherlands please contact us:

E-mail us at registration(at)imedex(dot)com
Call us at +1 (512) 583-8385
or
Register Online at http://www.europeanhematologicmalignancies.com

For event updates, and more information about this exciting oncology CME event connect with us! Find us on:

Facebook at https://www.facebook.com/pages/8th-European-Congress-on-Hematologic-Malignancies/203596016378280
or
Twitter @Hematologycme

For more Imedex events and updates, visit our blog at http://oncologycme.tumblr.com or go to http://www.imedex.com.

Key Terms: Hematology CME, Gastroenterology CME, Oncology CME, Residency Fellowship CME, Pharmacy CME, Physician CME, Physician-in-Training CME, Physician Assistant CME, and Oncology Nurse CE.

About Imedex, LLC
Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.

Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, we believe that education is the best medicine. ®

Release issued by Audience Generation, LLC
Audience Generation is a forward thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated marketing, advertising, and technology services and solutions that offer a new way to find, generate, and engage live, online, social and mobile audiences where they exist on demand.

Audience Generation is known for its creative strategy, actionable solutions and measurable approach to transforming the ways brands interact with their target audience where they exist in person, online, via social networks or on their mobile devices.

Audience Generation has produced winning traditional, online, e-commerce, social and mobile campaigns including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture backed start-up companies across a variety of industry verticals around the World.

To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand and grow your bottom line please call us at 512-708-4678 or email us at growyourbusiness(at)audiencegeneration(dot)com or visit us at: http://www.audiencegeneration.com

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Marilyn Holman
Audience Generation
512-708-4678
Email >
Visit website

Media